Elan Corporation

Pharmaceutical company

7/4/2008 20:41 ET

Site Map | Contact Us | Search:

  • NYSE | ELN | 33.72 | -1.35  (20 minute delay)
   

 

 


               These are large files please allow sufficient time to download

Feature:

  • Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease...more
  • WEBCAST REPLAY: Elan Presents at the Goldman Sachs Global Healthcare Conference...more
  • Elan Announces Changes in Board of Directors...more
  • WEBCAST REPLAY: Elan's 2008 Annual General Meeting...more                              

Marketed Products
in the U.S.

  • TYSABRI®
    (natalizumab)
  • PRIALT®
    (ziconotide intrathecal infusion) 
  • Azactam®
    (aztreonam for injection, USP)
  • Maxipime®
    (cefepime hydrochloride) for injection                      

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use